Genitourinary Cancer Archives - Insights https://news.mayocliniclabs.com/category/oncology/genitourinary-cancer/ Get the latest news and education from Mayo Clinic Laboratories Thu, 20 Feb 2025 21:07:38 +0000 en-US hourly 1 https://wordpress.org/?v=6.8.1 Dr. Dong Chen and Dr. Sounak Gupta join Becker’s Healthcare Podcast to discuss molecular testing in cancer care https://news.mayocliniclabs.com/2024/10/28/dr-dong-chen-and-dr-sounak-gupta-join-beckers-healthcare-podcast-to-discuss-molecular-testing-in-cancer-care/ https://news.mayocliniclabs.com/2024/10/28/dr-dong-chen-and-dr-sounak-gupta-join-beckers-healthcare-podcast-to-discuss-molecular-testing-in-cancer-care/#respond Tue, 29 Oct 2024 01:00:00 +0000 https://news.mayocliniclabs.com/?p=113101 Dr. Dong Chen and Dr. Sounak Gupta join Becker’s Healthcare Podcast to discuss molecular testing in cancer careDr. Dong Chen and Dr. Sounak Gupta joined the “Becker’s Healthcare Podcast” to discuss the molecular testing space and its important role in personalized cancer treatment. Dr. Chen and Dr. Gupta highlighted the importance of selecting the right molecular tests for patients, the impact of genetic testing on cancer diagnosis and treatment, and how Mayo Clinic Laboratories is helping physicians make informed decisions for the best patient outcomes.

The post Dr. Dong Chen and Dr. Sounak Gupta join Becker’s Healthcare Podcast to discuss molecular testing in cancer care appeared first on Insights.

]]> https://news.mayocliniclabs.com/2024/10/28/dr-dong-chen-and-dr-sounak-gupta-join-beckers-healthcare-podcast-to-discuss-molecular-testing-in-cancer-care/feed/ 0 Giving thanks for years of prostate cancer treatment: Kurt Glover-Ettrich https://news.mayocliniclabs.com/2023/11/13/giving-thanks-for-years-of-prostate-cancer-treatment-kurt-glover-ettrich/ https://news.mayocliniclabs.com/2023/11/13/giving-thanks-for-years-of-prostate-cancer-treatment-kurt-glover-ettrich/#respond Mon, 13 Nov 2023 14:00:00 +0000 https://news.mayocliniclabs.com/?p=105698 Giving thanks for years of prostate cancer treatment: Kurt Glover-EttrichAfter immigrating to the United State and becoming a U.S. citizen at the age of 18, Holocaust survivor Kurt Glover-Ettrich chose to give back to his new homeland by serving a 30-year career in the U.S. military. Today, as a Mayo Clinic volunteer, Kurt is giving back in new ways for the 22 years of regular care, treatment, and laboratory testing he’s received in response to the prostate cancer diagnosis that first brought him to Mayo Clinic.

The post Giving thanks for years of prostate cancer treatment: Kurt Glover-Ettrich appeared first on Insights.

]]> https://news.mayocliniclabs.com/2023/11/13/giving-thanks-for-years-of-prostate-cancer-treatment-kurt-glover-ettrich/feed/ 0 Urologic panels provide focused cancer testing: Sounak Gupta, M.B.B.S., Ph.D. https://news.mayocliniclabs.com/2023/07/11/urologic-panels-provide-focused-cancer-testing-sounak-gupta-m-b-b-s-ph-d/ https://news.mayocliniclabs.com/2023/07/11/urologic-panels-provide-focused-cancer-testing-sounak-gupta-m-b-b-s-ph-d/#comments Tue, 11 Jul 2023 13:00:00 +0000 https://news.mayocliniclabs.com/?p=98556 Urologic panels provide focused cancer testing: Sounak Gupta, M.B.B.S., Ph.D.Sounak Gupta, M.B.B.S., Ph.D., explains how Mayo Clinic Laboratories' urologic panels efficiently inform prognosis and individualized cancer treatment. The carefully curated panels fill the void between single gene assays and large NGS panels.

The post Urologic panels provide focused cancer testing: Sounak Gupta, M.B.B.S., Ph.D. appeared first on Insights.

]]> https://news.mayocliniclabs.com/2023/07/11/urologic-panels-provide-focused-cancer-testing-sounak-gupta-m-b-b-s-ph-d/feed/ 2 Meet Mukesh Pandey, Ph.D. – Developing a New Drug to Detect Prostate Cancer in Its Earliest Stages https://news.mayocliniclabs.com/2019/09/05/meet-mukesh-pandey-ph-d-developing-a-new-drug-to-detect-prostate-cancer-in-its-earliest-stages/ https://news.mayocliniclabs.com/2019/09/05/meet-mukesh-pandey-ph-d-developing-a-new-drug-to-detect-prostate-cancer-in-its-earliest-stages/#respond Thu, 05 Sep 2019 23:00:17 +0000 https://news.mayocliniclabs.com/?p=53959 Meet Mukesh Pandey, Ph.D. – Developing a New Drug to Detect Prostate Cancer in Its Earliest StagesDr. Pandey is a nuclear radiology researcher working with a team to develop a new radioactive tracer to detect prostate cancer.

The post Meet Mukesh Pandey, Ph.D. – Developing a New Drug to Detect Prostate Cancer in Its Earliest Stages appeared first on Insights.

]]> https://news.mayocliniclabs.com/2019/09/05/meet-mukesh-pandey-ph-d-developing-a-new-drug-to-detect-prostate-cancer-in-its-earliest-stages/feed/ 0 Mayo Clinic Discovers Biological Markers That Could Guide Treatment for Prostate Cancer https://news.mayocliniclabs.com/2019/01/15/mayo-clinic-discovers-biological-markers-that-could-guide-treatment-for-prostate-cancer/ https://news.mayocliniclabs.com/2019/01/15/mayo-clinic-discovers-biological-markers-that-could-guide-treatment-for-prostate-cancer/#respond Tue, 15 Jan 2019 15:00:33 +0000 https://news.mayocliniclabs.com/?p=48743 Mayo Clinic Discovers Biological Markers That Could Guide Treatment for Prostate CancerGenetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbor higher-risk cancer in their prostate glands, Mayo Clinic has discovered.

The post Mayo Clinic Discovers Biological Markers That Could Guide Treatment for Prostate Cancer appeared first on Insights.

]]> https://news.mayocliniclabs.com/2019/01/15/mayo-clinic-discovers-biological-markers-that-could-guide-treatment-for-prostate-cancer/feed/ 0 Mayo Clinic Laboratory and Pathology Research Roundup: May 21 https://news.mayocliniclabs.com/2018/05/21/mayo-clinic-laboratory-and-pathology-research-roundup-may-21/ https://news.mayocliniclabs.com/2018/05/21/mayo-clinic-laboratory-and-pathology-research-roundup-may-21/#respond Mon, 21 May 2018 14:00:22 +0000 https://news.mayocliniclabs.com/?p=43428 Mayo Clinic Laboratory and Pathology Research Roundup: May 21This week’s Research Roundup highlights the development and validation of a prostate cancer genomic signature that predicts early androgen deprivation therapy (ADT) treatment response following radical prostatectomy.

The post Mayo Clinic Laboratory and Pathology Research Roundup: May 21 appeared first on Insights.

]]> https://news.mayocliniclabs.com/2018/05/21/mayo-clinic-laboratory-and-pathology-research-roundup-may-21/feed/ 0 Mayo Clinic Laboratory and Pathology Research Roundup: Jan. 15 https://news.mayocliniclabs.com/2018/01/15/mayo-clinic-laboratory-pathology-research-roundup-jan-15/ https://news.mayocliniclabs.com/2018/01/15/mayo-clinic-laboratory-pathology-research-roundup-jan-15/#respond Mon, 15 Jan 2018 15:00:56 +0000 https://news.mayocliniclabs.com/?p=39823 Mayo Clinic Laboratory and Pathology Research Roundup: Jan. 15This week’s Research Roundup highlights how the loss of FOXO1 cooperates with TMPRSS2-ERG overexpression to promote prostate tumorigenesis and cell invasion.

The post Mayo Clinic Laboratory and Pathology Research Roundup: Jan. 15 appeared first on Insights.

]]> https://news.mayocliniclabs.com/2018/01/15/mayo-clinic-laboratory-pathology-research-roundup-jan-15/feed/ 0 Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 4 https://news.mayocliniclabs.com/2017/09/04/mayo-clinic-laboratory-pathology-research-roundup-sept-4/ https://news.mayocliniclabs.com/2017/09/04/mayo-clinic-laboratory-pathology-research-roundup-sept-4/#respond Mon, 04 Sep 2017 14:00:09 +0000 https://news.mayocliniclabs.com/?p=34859 Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 4This week’s Research Roundup highlights individual patient-level meta-analysis of the performance of the Decipher genomic classifier in high-risk men after prostatectomy to predict development of metastatic disease.

The post Mayo Clinic Laboratory and Pathology Research Roundup: Sept. 4 appeared first on Insights.

]]> https://news.mayocliniclabs.com/2017/09/04/mayo-clinic-laboratory-pathology-research-roundup-sept-4/feed/ 0 Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 21 https://news.mayocliniclabs.com/2017/08/21/mayo-clinic-laboratory-pathology-research-roundup-aug-28/ https://news.mayocliniclabs.com/2017/08/21/mayo-clinic-laboratory-pathology-research-roundup-aug-28/#respond Mon, 21 Aug 2017 14:00:14 +0000 https://news.mayocliniclabs.com/?p=34527 Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 21This week’s Research Roundup highlights how intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activation.

The post Mayo Clinic Laboratory and Pathology Research Roundup: Aug. 21 appeared first on Insights.

]]> https://news.mayocliniclabs.com/2017/08/21/mayo-clinic-laboratory-pathology-research-roundup-aug-28/feed/ 0 The Prostate Health Index (phi) in Prostate Cancer Risk Assessment https://news.mayocliniclabs.com/2017/08/14/prostate-health-index-phi-prostate-cancer-risk-assessment-hot-topic/ https://news.mayocliniclabs.com/2017/08/14/prostate-health-index-phi-prostate-cancer-risk-assessment-hot-topic/#comments Mon, 14 Aug 2017 13:00:30 +0000 https://news.mayocliniclabs.com/?p=33872 The Prostate Health Index <i>(phi)</i> in Prostate Cancer Risk AssessmentIn this month’s “Hot Topic,” Alicia Algeciras-Schimnich, Ph.D., will provide you with valuable information regarding the utility of the prostate specific antigen test, and how the calculation of a prostate health index, or phi, can help to stratify a patient’s risk for prostate cancer and reduce unnecessary biopsies.

The post The Prostate Health Index <i>(phi)</i> in Prostate Cancer Risk Assessment appeared first on Insights.

]]> https://news.mayocliniclabs.com/2017/08/14/prostate-health-index-phi-prostate-cancer-risk-assessment-hot-topic/feed/ 1